FDA Radiology AI Devices

Discover FDA-cleared medical imaging AI devices with clean summaries, company insights, and linked references. We help you quickly understand what's approved, who built it, and how it fits into the evolving landscape of radiology AI.

Transpara is an AI-powered software designed to assist radiologists in detecting and diagnosing breast cancer from screening mammograms. It highlights suspicious soft tissue lesions and calcifications and provides likelihood scores for cancer presence, helping clinicians make more informed decisions during mammogram interpretation.

FDA #
K192287
Product Code
QDQ

ProFound AI Software V2.1 is an AI-based software designed to assist radiologists in detecting soft tissue densities and calcifications in 3D digital breast tomosynthesis images. It highlights suspicious breast lesions by marking areas in the images and assigns confidence scores to help physicians identify likely malignant regions, supporting earlier and more accurate breast cancer diagnosis.

FDA #
K191994
Product Code
QDQ

cmTriage is a software tool that uses artificial intelligence to analyze 2D digital mammograms and flags suspicious cases to help radiologists prioritize which exams to review first. It integrates with the Picture Archiving and Communication System (PACS) worklist but does not alter images or provide diagnostic results. cmTriage aims to improve the efficiency of breast cancer screening workflows by identifying potentially abnormal cases for quicker attention.

FDA #
K183285
Product Code
QFM

PowerLook Tomo Detection V2 Software by iCAD Inc. is an AI-based computer-assisted detection and diagnosis tool that helps physicians identify suspicious lesions and calcifications in digital breast tomosynthesis images. It provides confidence scores to assist in evaluating findings, improving radiologist accuracy and reducing reading time during breast cancer screening exams.

FDA #
K182373
Product Code
QDQ

Transpara is an AI-powered software tool that helps doctors identify suspicious areas in mammograms that might be breast cancer. It highlights these areas, provides scores indicating the likelihood of cancer, and supports physicians in making more accurate diagnoses. This assists in earlier and more reliable detection of breast cancer during screening.

FDA #
K181704
Product Code
QDQ

DenSeeMammo is a software tool designed to assist radiologists by automatically estimating breast density from digital mammography images. It analyzes 2D mammograms and categorizes breast density according to the BI-RADS 5th Edition, providing additional information to aid breast cancer risk assessment. The final breast density assessment remains the responsibility of the qualified physician. This helps clinicians make consistent and informed evaluations of breast density, potentially improving screening and diagnosis.

FDA #
K173574
Product Code
LLZ

DM-Density is an AI-based software that processes digital mammogram images to automatically calculate breast density, providing numerical values and breast density grades to assist physicians in assessing breast tissue composition. It supports clinical use by delivering standardized breast density information following BI-RADS classifications, integrating with mammography workstations or PACS.

FDA #
K170540
Product Code
LLZ

QUANTRA is software designed for use with digital mammography systems to estimate volumetric breast density. It calculates the ratio of fibroglandular tissue to total breast volume from mammography images, providing quantitative data to assist radiologists in assessing breast tissue composition. The software acts as an adjunct tool and is not intended as a diagnostic or interpretive aid, helping clinicians better understand breast density which is important for patient care.

FDA #
K082483
Product Code
LLZ
Page 4 of 438 results

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.